Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

Background Sickle cell disease (SCD) is associated with acute healthcare utilization and an estimated annual cost of $2 billion that is primarily covered through public insurance. Understanding factors contributing to acute healthcare utilization among SCD patients is crucial to decrease costs associated with services. Our study describes trends of acute care utilization among Illinois (IL) residents with SCD over a 3 year period and examines...